当前位置:首页 - 行情中心 - 普昂医疗(920069) - 财务分析 - 现金流量表

普昂医疗

(920069)

  

流通市值:4.85亿  总市值:17.39亿
流通股本:1475.64万   总股本:5291.98万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金226,686,914.65111,776,009.34394,459,984.84277,055,149.17
  收到的税费返还4,981,588.392,387,971.819,683,144.478,625,288.76
  收到其他与经营活动有关的现金3,060,925.012,599,663.4812,364,324.329,839,422.34
  经营活动现金流入小计234,729,428.05116,763,644.63416,507,453.63295,519,860.27
  购买商品、接受劳务支付的现金81,072,915.5743,850,138.19160,390,616.2197,801,628.85
  支付给职工以及为职工支付的现金52,064,317.0828,169,552.9380,234,448.9759,519,465.67
  支付的各项税费12,646,520.838,034,865.9219,551,216.2615,757,096.42
  支付其他与经营活动有关的现金24,797,969.599,292,902.1741,059,655.8930,525,080.28
  经营活动现金流出小计170,581,723.0789,347,459.21301,235,937.33203,603,271.22
  经营活动产生的现金流量净额64,147,704.9827,416,185.42115,271,516.391,916,589.05
二、投资活动产生的现金流量:
  收回投资收到的现金65,000,000---
  取得投资收益收到的现金40,136.97---
  处置固定资产、无形资产和其他长期资产收回的现金净额182,175.96-472,300282,250
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计65,222,312.93-472,300282,250
  购建固定资产、无形资产和其他长期资产支付的现金47,891,961.3320,804,235.1963,238,809.2844,237,005.54
  投资支付的现金133,000,000---
  投资活动现金流出小计180,891,961.3320,804,235.1963,238,809.2844,237,005.54
  投资活动产生的现金流量净额-115,669,648.4-20,804,235.19-62,766,509.28-43,954,755.54
三、筹资活动产生的现金流量:
  吸收投资收到的现金194,511,864194,511,864--
  取得借款收到的现金--15,000,00015,000,000
  筹资活动现金流入小计194,511,864194,511,86415,000,00015,000,000
  偿还债务支付的现金19,098,734.186,000,00088,255,409.1286,975,600.3
  分配股利、利润或偿付利息支付的现金27,079,857.9153,804.73560,395.16559,242.71
  支付其他与筹资活动有关的现金25,251,564.4116,852,830.193,562,264.16-
  筹资活动现金流出小计71,430,156.522,906,634.9292,378,068.4487,534,843.01
  筹资活动产生的现金流量净额123,081,707.5171,605,229.08-77,378,068.44-72,534,843.01
四、汇率变动对现金及现金等价物的影响-3,357,531.11-1,538,333.96653,228.11,369,983.23
五、现金及现金等价物净增加额68,202,232.97176,678,845.35-24,219,833.32-23,203,026.27
  加:期初现金及现金等价物余额33,913,805.3633,913,805.3658,133,638.6858,133,638.68
  期末现金及现金等价物余额102,116,038.33210,592,650.7133,913,805.3634,930,612.41
补充资料:
  净利润53,139,178.38-89,775,785.62-
  资产减值准备995,988.48-2,419,735.14-
  固定资产和投资性房地产折旧20,471,892.26-37,972,454.82-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧20,471,892.26-37,972,454.82-
  无形资产摊销762,237.8-1,491,423.53-
  长期待摊费用摊销17,510.28-12,968.68-
  处置固定资产、无形资产和其他长期资产的损失41,040.72-27,650.17-
  固定资产报废损失940.17-24,125.07-
  财务费用3,451,188.81--147,182.42-
  投资损失-40,136.97---
  递延所得税82,536.48-728,600.66-
  其中:递延所得税资产减少193,983.34-923,860.51-
    递延所得税负债增加-111,446.86--195,259.85-
  存货的减少-12,987,572.05--14,746,864.3-
  经营性应收项目的减少-8,166,994.63--15,676,864.11-
  经营性应付项目的增加5,094,194.64-11,039,489.77-
  其他1,014,810.97-1,454,873.88-
  现金的期末余额102,116,038.33-33,913,805.36-
  减:现金的期初余额33,913,805.36-58,133,638.68-
  现金及现金等价物的净增加额68,202,232.97--24,219,833.32-
公告日期2026-08-262026-04-232026-02-052025-12-12
审计意见(境内)标准无保留意见
TOP↑